Literature DB >> 3100675

A single dose assessment of an ibuprofen/codeine combination in postoperative dental pain.

A D Giles, C M Hill, J P Shepherd, D J Stewart, N J Pickvance.   

Abstract

In a double-blind, single dose study of analgesic efficacy, 202 patients who had undergone lower 3rd molar extraction were divided into 5 groups to receive aspirin, placebo, ibuprofen, codeine, or an ibuprofen/codeine combination. Ibuprofen 200 mg (with or without codeine phosphate 15 mg) and aspirin 600 mg were significantly superior to either placebo or codeine phosphate 15 mg alone. Codeine phosphate at a dose of 15 mg was ineffective as an analgesic either alone or in combination.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3100675     DOI: 10.1016/s0300-9785(86)80114-4

Source DB:  PubMed          Journal:  Int J Oral Maxillofac Surg        ISSN: 0901-5027            Impact factor:   2.789


  5 in total

1.  Summary of the scientific literature for pain and anxiety control in dentistry journal literature, January 1986-December 1987.

Authors:  L C Hassett
Journal:  Anesth Prog       Date:  1988 Nov-Dec

Review 2.  Single dose oral ibuprofen plus codeine for acute postoperative pain in adults.

Authors:  Sheena Derry; Samuel M Karlin; R Andrew Moore
Journal:  Cochrane Database Syst Rev       Date:  2015-02-05

3.  Managing postoperative pain in adult outpatients: a systematic review and meta-analysis comparing codeine with NSAIDs.

Authors:  Matthew Choi; Li Wang; Christopher J Coroneos; Sophocles H Voineskos; James Paul
Journal:  CMAJ       Date:  2021-06-14       Impact factor: 8.262

4.  Analgesic efficacy of an ibuprofen-codeine combination in patients with pain after removal of lower third molars.

Authors:  M Hellman; U Ahlström; L Andersson; S Strid
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 5.  Single dose oral aspirin for acute postoperative pain in adults.

Authors:  Sheena Derry; R Andrew Moore
Journal:  Cochrane Database Syst Rev       Date:  2012-04-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.